ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 465

Seasonal Variation in Cutaneous Flares for Pediatric Lupus

Tamara Tanner1, Marija Dionizovik-Dimanovski2, Dawn Wahezi3 and Tamar Rubinstein3, 1Albert Einstein College of Medicine/ Children's Hospital at Montefiore, Albert Einstein College of Medicine/ Children's Hospital at Montefiore, Bronx, NY, 2Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, 3Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cutaneous manifestations, Disease Activity, Pediatric rheumatology, race/ethnicity and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Exposure to sunlight has been proposed as a possible environmental trigger for lupus flares, particularly cutaneous disease. Contradictory findings exist regarding seasonal variation in cutaneous disease activity, with particular gaps in knowledge around pediatric and minority patient populations.

Our objectives for this study were to study the relationship between sun exposure and cutaneous lupus flares in a racially and ethnically diverse pediatric lupus population. Based on prior studies, we hypothesized that higher rates of cutaneous flares would be present in summer/fall compared to winter/spring seasons.

Methods: We retrospectively reviewed 12 years of data from patients enrolled in the Pediatric Einstein Lupus Cohort at the Children’s Hospital at Montefiore from the Bronx, New York. We selected patients that had any history of mucocutaneous disease by indicated by BILAG scores of A-D, as opposed to E, at any point during follow up. We defined cutaneous flares by two methods: (1) mucocutaneous BILAG criteria A or B and (2) SLEDAI-2K inflammatory rash criteria. Chi-square tests were used to compare flare rates during summer/fall vs winter/spring and to compare flare rates during each season.

Results: We examined 320 visits for 90 individual patients. The average age of participants at included visits was 16.8 ±3 years; 82% of patients were female; 52% were Hispanic and 43% Black. Among included visits, 33% had represented BILAG-mucocutaneous flares and 38% represented SLEDAI-rash flares. Total visits and flare visits were not evenly distributed throughout the year; more total visits and more flare visits were observed during summer/fall (Figure 1). The rate of visits with BILAG-mucocutaneous flares was 37% in the summer/fall vs 27% in winter/spring (p = 0.04). The rate of visits with SLEDAI-rash flares was 43% in summer/fall vs 33% in winter/spring (p = 0.05) (Table 1). In contrast, there was no significant association between specific seasons and BILAG-mucocutaneous flares or SLEDAI-rash flares, though the highest flare rates were observed during fall (40%, 46% of visits, respectively).

Conclusion: Our results show a modestly increased rate of cutaneous flares during summer/fall months when compared with winter/spring months in a racially and ethnically diverse sample of children with SLE. More studies are needed to better understand the relationship between sun exposure and disease flare in minority race/ethnicities with pediatric lupus to inform disease activity prevention counseling.

 

Table 1. Rates of cutaneous flare in pediatric lupus patients

 

Summer/Fall visits

(N = 177)

Winter/Spring visits

(N = 143)

 p value:

Mucocutaneous flare visits by BILAG

66 (37%)

38 (27%)

0.04

Inflammatory rash flare by SLEDAI

76 (43%)

47 (33%)

0.05


Disclosure: T. Tanner, None; M. Dionizovik-Dimanovski, None; D. Wahezi, None; T. Rubinstein, None.

To cite this abstract in AMA style:

Tanner T, Dionizovik-Dimanovski M, Wahezi D, Rubinstein T. Seasonal Variation in Cutaneous Flares for Pediatric Lupus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/seasonal-variation-in-cutaneous-flares-for-pediatric-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-variation-in-cutaneous-flares-for-pediatric-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology